Industry Pharmaceuticals | Traded as BSE: 500420 Number of employees 8600 (2014) Founded 1959 | |
 | ||
Net income INR 17.5 billion (March 2016) Stock price TORNTPHARM (NSE) ₹ 1,506.00 -46.60 (-3.00%)3 Apr, 3:30 PM IST - Disclaimer Revenue 66 billion INR (March 2016) | ||
Torrent pharmaceuticals limited vibrant gujrat
Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group. Based in the Indian city of Ahmedabad. It was promoted by U. N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to Torrent Pharmaceuticals Ltd.
Contents
Torrent Pharmaceuticals operates in more than 50 countries with over 1000 product registrations globally. Torrent Pharma is active in the therapeutic areas of cardiovascular (CV), central nervous system (CNS), gastro-intestinal, diabetology, anti-infective and pain management segments. It has also forayed into the therapeutic segments of nephrology and oncology while also strengthening its focus on gynecology and pediatric segments.
It has 7 fully owned subsidiaries:
- Heumann Pharma GmbH & Co Generica KG, Germany
- Torrent Pharma GmbH, Germany
- Torrent do Brasil Ltda., Brazil
- ZAO Torrent Pharma, Russia
- Torrent Pharma Inc., United States
- Torrent Pharma Philippines Inc., Philippines
- Torrent Pharma Canada Inc., Canada
Torrent Pharmaceuticals acquired Heumann GmbH, a Pfizer company, in 2005.
Operations
The company's key areas are Formulations, API, Drug Discovery, Marketing and Sales of Drugs. Its operations locations are: